Pass the CBIC Infection Control CIC Questions and answers with Dumpstech

The Certification Study Guide (6th edition) emphasizes that thorough cleaning is the most critical step in the reprocessing of all reusable medical devices, including semi-critical devices (those that contact mucous membranes or nonintact skin). A foundational requirement is that initial cleaning begins as soon as possible after use. Prompt cleaning prevents organic material—such as blood, secretions, and tissue—from drying on device surfaces and within lumens, which can shield microorganisms and significantly reduce the effectiveness of subsequent disinfection.

The study guide explains that delayed cleaning increases the risk of biofilm formation and makes removal of soil more difficult, potentially compromising patient safety. For this reason, point-of-use pre-cleaning and rapid transport to reprocessing are considered minimum expectations. Cleaning must occur before any high-level disinfection or sterilization; without effective cleaning, even correctly selected disinfectants may fail.

The other options are incorrect or misleading. There is no universal requirement for detergents with pH lower than 7; detergent selection should follow manufacturer instructions. Waiting 24 hours before cleaning is contrary to best practice and increases risk. Soaking devices in liquid chemical sterilants for extended periods does not address the prerequisite of cleaning and may not be appropriate for semi-critical devices unless specified by the manufacturer.

This question reflects a key CIC exam principle: timely cleaning is non-negotiable and is the cornerstone of safe device reprocessing.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that the most effective strategy for reducing infection risk in peritoneal dialysis (PD) patients is ensuring optimal conditions at the time of catheter insertion. Placement of the peritoneal dialysis catheter in the operating room provides a controlled, sterile environment that minimizes microbial contamination and significantly reduces the risk of early peritonitis and exit-site infections.

Peritoneal dialysis–associated infections are most often linked to contamination during catheter insertion or manipulation. Performing catheter insertion in the operating room allows for strict adherence to aseptic technique, appropriate airflow controls, surgical hand antisepsis, and use of sterile instruments—all of which are essential infection prevention measures highlighted in the Study Guide.

The other options are less effective or not recommended. Daily dressing changes (Option A) may actually increase manipulation of the exit site and raise infection risk if not clinically indicated. Weekly surveillance cultures (Option B) are not recommended, as they do not prevent infection and may lead to unnecessary antimicrobial use. Irrigating catheters with antimicrobials (Option D) is discouraged because it has not been shown to reduce infection rates and may contribute to antimicrobial resistance.

For the CIC® exam, it is important to recognize that prevention of peritoneal dialysis–associated infection begins with proper catheter placement under optimal sterile conditions, making operating room insertion the best answer.

==========

Requiring influenza vaccination as a condition of employment has consistently been shown to be the most effective method to increase compliance among healthcare personnel.

The APIC/JCR Workbook recommends this as a gold standard:

"Some organizations have adopted policies requiring annual vaccination as a condition of employment unless medically contraindicated".

CDC and APIC also support this method for maximizing coverage and protecting vulnerable populations.

The CBIC Certified Infection Control Exam Study Guide (6th edition) describes syndromic surveillance as a surveillance method that focuses on clinical signs, symptoms, or health-seeking behaviors rather than confirmed diagnoses. Its primary purpose is early detection of outbreaks or emerging health threats, often before laboratory confirmation is available.

Option A is the correct example because tracking the number of individuals presenting with influenza-like illness (ILI) relies on symptom patterns such as fever, cough, and sore throat. These data are typically collected in near real time from emergency department chief complaints or triage notes, allowing infection preventionists and public health authorities to identify unusual increases quickly and initiate early response measures.

Option B is not syndromic surveillance because it depends on laboratory-confirmed diagnoses, which are characteristic of traditional, diagnosis-based surveillance. Option C represents device-associated infection surveillance, which is retrospective and outcome-focused. Option D involves laboratory-confirmed antimicrobial-resistant organisms and is also not syndromic.

For CIC® exam preparation, it is important to remember that syndromic surveillance prioritizes speed over diagnostic certainty. By monitoring symptom clusters rather than confirmed cases, it enables earlier recognition of outbreaks such as influenza, gastrointestinal illness, or bioterrorism-related events, making it a critical component of public health preparedness and response.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that certain organisms commonly recovered from blood cultures—such as Arcanobacterium, coagulase-negative Staphylococcus, and Corynebacterium—are frequently associated with skin contamination rather than true bloodstream infection. When multiple blood cultures yield these organisms, the infection preventionist must assess whether the findings represent contamination related to collection practices rather than immediately assuming infection or outbreak.

The most appropriate action is to collaborate with the laboratory manager and clinical teams to evaluate potential trends, specimen collection techniques, and changes in practice. This includes reviewing blood culture contamination rates, assessing skin antisepsis procedures, evaluating staff competency, and determining whether there has been an increase associated with a specific unit, shift, or collection method. Surveillance data and laboratory quality indicators are essential tools in this evaluation.

Option A is incorrect because results should never be disregarded without assessment. Option B is premature, as the organisms listed are not typical outbreak pathogens and require further analysis before escalation. Option C is inappropriate because these organisms do not automatically meet criteria for healthcare-associated bloodstream infection without supporting clinical evidence.

This scenario reflects a core CIC® exam concept: infection preventionists must apply epidemiologic principles, collaborate with laboratory services, and use data-driven analysis to differentiate contamination from infection and to guide quality improvement efforts.

=========

Meningococcal infections, such as Neisseria meningitidis, are transmitted via respiratory droplets. According to APIC and CDC guidelines, patients with meningococcal disease should be placed on Droplet Precautions upon admission. These precautions can be discontinued after 24 hours of effective antibiotic therapy.

Why the Other Options Are Incorrect?

B. Droplet precautions must continue – Droplet Precautions are not needed beyond 24 hours of appropriate therapy because treatment rapidly reduces infectiousness.

C. Airborne precautions may be discontinued after 24 hours of therapy – Meningococcal infection is not airborne, so Airborne Precautions are never required.

D. Airborne precautions must continue – Incorrect because meningococci do not transmit via airborne particles.

CBIC Infection Control Reference

According to APIC guidelines, Droplet Precautions should be maintained for at least 24 hours after effective antibiotic therapy initiation​.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that when a potential cluster of infections is identified, the first priority is situational awareness. Before implementing control measures or advanced laboratory analysis, the infection preventionist must determine whether the cases are epidemiologically linked. Identifying the location of the patients—such as whether they are on the same unit, service, or clinic—is the essential first step in assessing the likelihood of transmission or a common source.

Option C is correct because determining patient location allows the IP to evaluate spatial and temporal relationships, which form the foundation of outbreak investigation. If the patients are colocated, this may indicate shared staff, equipment, or environmental exposure, guiding immediate and targeted interventions.

Cohorting patients (Option A) is premature without confirming proximity or transmission risk. Monitoring hand hygiene (Option B) is an important control measure but should follow confirmation of potential spread or shared risk factors. Pulsed-field gel electrophoresis (Option D) is an advanced molecular typing method and is never an initial step; it is reserved for later stages when epidemiologic evidence suggests related cases.

For the CIC® exam, this question tests understanding of outbreak investigation sequencing. The Study Guide consistently reinforces that defining who, where, and when comes before interventions or laboratory typing, making determination of patient location the correct first action.

The correct answer is A, "Observe all steps for reprocessing," as this is the most important process for the infection preventionist (IP) to review when evaluating a third-party reprocessor for single-use devices. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of single-use devices (SUDs) by third-party entities must adhere to stringent infection control standards to ensure they are safe for reuse and do not contribute to healthcare-associated infections (HAIs). Observing all steps—such as cleaning, disinfection, sterilization, packaging, and quality control—allows the IP to directly assess compliance with manufacturer instructions, regulatory requirements (e.g., FDA guidelines), and best practices (e.g., AAMI ST91) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This hands-on evaluation is critical because any deviation in the reprocessing chain can compromise device sterility and patient safety.

Option B (review the facility's blueprints and policies) provides context about the physical layout and procedural framework, but it is a preliminary step that does not directly verify the reprocessing process’s effectiveness. Option C (ensure air and water cultures are performed regularly) is important for monitoring environmental contamination risks, particularly in sterile processing areas, but it is a supportive measure rather than the primary focus of evaluating the reprocessor’s core activities. Option D (obtain feedback from other IPs who use the reprocessor) offers valuable peer insights, but it is subjective and secondary to direct observation, which provides firsthand evidence of compliance and performance.

The priority on observing reprocessing steps aligns with CBIC’s emphasis on ensuring the safety and efficacy of reprocessed medical devices, a key responsibility for IPs when outsourcing to third-party reprocessors (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This process enables the IP to identify specific weaknesses, validate adherence to standards, and make informed decisions about the reprocessor’s suitability.

The CBIC Certified Infection Control Exam Study Guide (6th edition) explains that critical items—those that enter sterile tissue or the vascular system—must be sterile at the time of use. When these items are heat-sensitive and cannot tolerate steam sterilization, low-temperature sterilization technologies are required. Among the options listed, hydrogen peroxide gas plasma is an FDA-cleared, low-temperature sterilization method specifically designed for heat- and moisture-sensitive medical devices.

Hydrogen peroxide gas plasma sterilization achieves sterilization by generating reactive free radicals that destroy microorganisms, including bacteria, viruses, fungi, and spores. The study guide emphasizes that this method provides true sterilization rather than disinfection and is widely used for delicate instruments such as certain endoscopes, optical devices, and electronic equipment. It also offers advantages such as short cycle times and minimal toxic residues.

The other options are incorrect because they do not achieve sterilization. Phenolics, chlorine-based products, and quaternary ammonium compounds are disinfectants, not sterilants, and are inappropriate for critical items. Even at high concentrations, these agents cannot reliably destroy bacterial spores and therefore do not meet the definition of sterilization.

This question highlights a key CIC exam concept: critical items require sterilization, and when heat cannot be used, approved low-temperature sterilization technologies such as hydrogen peroxide gas plasma are required to ensure patient safety.

Chickenpox (varicella) is primarily spread through airborne transmission, and exposure is defined by being in the same airspace with a contagious person (from 1-2 days before rash onset until lesions are crusted), even if briefly.

The APIC Text states:

“Significant exposure is defined as being in the same room or airspace during the period of infectivity, regardless of duration”.

This reflects airborne precaution definitions and CDC exposure management guidelines for varicella.